Introduction
The nasoseptal flap (NSF), also named Hadad flap, was described in 2006 and was rapidly adopted as the primary reconstructive method for reconstruction in endoscopic endonasal surgery (EES) of the skull base. 1 Initial reports of using a U-shaped flap of three-fourth of the septal mucoperichondrial layer was initially described by Hirsch in 1952; however, it is not clear from the description that this flap had axial vascular supply. 2 The NSF is widely considered a robust and reliable vascularized flap, with a wide variety of applications. Reconstruction of large dural defects with vascularized tissue, as part of a multilayer reconstruction, was found to significantly reduce the rate of cerebrospinal fluid (CSF) leak rates from 15.6 to 6.7% compared with nonvascularized reconstruction. 3 In a single institution study that included 70 consecutive NSF for reconstruction of high-flow CSF leaks, the NSF was found to have a 94% efficacy rate. 4 Several studies have now described the postoperative complications and morbidity associated with this flap. While there are single institution reports of the complications associated with NSFs, no comprehensive reviews exist to describe the full scope and frequency of such complications across surgeons and institutions.
Here, we present a systematic review of the published literature regarding complications and morbidities related to the NSF.
Methods
A systematic review of published literature was performed for the primary outcome of NSF complications and morbidities. The MEDLINE and Embase databases were searched from January 1, 1950 the MeSH terms that were used in the search strategy. The bibliographies of identified articles were also reviewed for additional relevant articles. After the search was completed, study selection was performed by abstract review by the first author (Philippe Lavigne). Data extraction was reviewed for accuracy by the second author. Discrepancies between reviewers were resolved via discussion with a third reviewer. When available, individual patient data were extracted. Only published articles in English were included. Case reports and case series with less than five reported cases were excluded. Only studies with data specific to the use of the NSF were included for final analysis.
Results
Initial database search produced 2,403 studies. A title search found 406 articles on the NSF. After abstract review, 27 articles were included for the final analysis. The selection process is outlined in ►Fig. 1. The identified complications related to the use of the NSF were as follows: NSF necrosis, mucocele formation, septal perforation, nasal dorsum collapse, reduced quality of life (QoL), and olfactory loss. ►Tables 2-4 present the included articles for each identified complication.
Nasoseptal Flap Necrosis
Chabot et al presented a series of 601 consecutive NSF, of which 8 (1.3%) were found to have NSF necrosis on reexploration (►Fig. 2). 
Mucocele Formation
Mucocele formation is not a complication of the NSF itself, but the result of incomplete removal of sphenoid mucosa on the recipient bed. Bleier et al published an article on the rate of mucocele formation after NSF reconstruction with localized mucosal stripping (mucosa around the defect was left intact).
11 Twenty-eight patients were included, and after a mean follow-up of 8 months, only one (3.6%) patient developed a mucocele. Similarly, Soudry et al identified one (0.8%) case of mucocele 2 years after the initial surgery. 7 The patient was asymptomatic, but due to radiological evidence of enlargement, the mucocele was surgically drained. The other identified studies found a 0% rate of mucocele formation (►Table 2).
Olfactory Change
Upadhyay et al compared University of Pennsylvania Smell Identification Test (UPSIT) scores between patients who had reconstruction of skull base defects with an NSF (10 patients) and patients who had free mucosal graft reconstruction (35 patients). 18 The UPSIT scores were compared at baseline, 6 weeks, 3 months, and 6 months postoperatively. The authors found a significant reduction in UPSIT scores in the NSF group at 6 weeks (24.5 AE 5.4) when compared with 
Prolonged Crusting
When an NSF is harvested, septal cartilage and bone remain exposed to the nasal cavity. It has been hypothesized that reepithelialization of the exposed cartilage and bone results in a prolonged duration of healing. 
Nasal Deformity
Three published articles discussed the rates of septal perforation and dorsal nasal collapse (saddle nose) associated with the use of an NSF. Rowan et al found a 5.8% rate of dorsum collapse and a 0.9% rate of septal perforation.
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Soyka et al and Soudry et al found rates of septal perforation of 14.4 and 10%, respectively.
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Quality of Life Outcomes (QoL)
Several studies have investigated the impact of the NSF on QoL outcomes (►Table 4). The two largest series were published by Jalessi et al and Harvey et al and included 106 and 108 patients, respectively. 15, 26 Both studies used the SNOT-22 questionnaire and found no difference in QoL outcomes while comparing the use of an NSF to other multilayer reconstructive methods. One study found a significant difference at 3 months in nasal symptoms (subset from SNOT-22) while comparing the NSF to free mucosal graft reconstruction.
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Quality of Evidence
Risk of bias was assessed using the Cochrane Collaboration Effective Practice and Organization of Care (EPOC) tool for assessing risk of bias (►Table 5). Quality of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system for transparency and simplicity. 31, 32 This only applied to studies that included a comparative group. 
Discussion
The NSF receives vascularization from the posterior septal artery (PSA), a terminal branch of the sphenopalatine artery. The PSA itself divides into two branches as it courses across the anterior wall of the sphenoid sinus, before reaching the posterior nasal septum (►Fig. 3). 33 Placement of incisions and NSF harvesting technique are thus of great importance to protect this vascular supply. The superior incision must be placed at the superior aspect of the sphenoid ostium to protect the superior branch of the PSA. It is then drawn parallel to the skull base, at least 1 cm below the skull base. Once anterior to the olfactory epithelium, the incision can curve superiorly toward the superior limit of the septum, to increase flap size. Retrospectively, comparing NSF reconstruction with free mucosal graft reconstruction is inherently biased by patient selection and disease severity. Yet, series that described olfactory strip preservation technique have shown low rates of olfactory loss, with return to baseline olfaction within 3 to 6 months. 37 The axial pattern of vascularization is preserved postseptoplasty, and secondary NSF harvest with revision cases, as flap take-down and reuse, has been shown to be safe and reliable. 5, 38 A limited number of studies have reported postoperative rates of NSF necrosis (►Table 2). While the reported rate varies between 0 and 1.3%, it is likely that this complication often goes unnoticed when the patient has a normal postoperative course, resulting in underreporting. Similarly, septal perforation and nasal dorsum collapse are rare. Reported rates of septal perforation vary between 0 and 14.4%. Removal of the posterior septum during surgery (posterior septectomy) is rarely noticeable to patients, and anterior septal perforations, if symptomatic, can be closed surgically or with a septal button. Only two identified studies report rates of dorsum collapse (0.7 and 5.8%). Considering the lack of standardized measures for dorsal collapse and its rarity, it is likely that this complication is also underreported. 
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þ, low risk of bias; -, high risk of bias; ?, unclear. Factors contributing to nasal dorsum collapse have not been fully elucidated. Several factors have been shown to affect postoperative QoL measurements in endoscopic skull base surgery. Harvey et al showed that preoperative radiation therapy, extent of surgery, and malignant tumor pathology were more important contributors to morbidity than the use of an NSF. 26 It is important to note that these factors were not accounted for in other studies that suggest increased morbidity with the use of an NSF. 39 The NSF donor site heals by secondary intention and can result in significant crusting for up to 12 weeks postoperatively. 16, 27, 40 While septal crusting may not last any longer than the expected postoperative sinonasal crusting, 16, 41 it can affect the internal nasal valve and contribute to symptomatic nasal obstruction. Several solutions to expedite septal healing have been described, such as silicone splinting, free grafting (mucosa or fascia lata), and the reverse rotation flap described by Caicedo et al [41] [42] [43] Overall, the quality of evidence is low with most studies designed as cohort studies with high potential for selection bias (►Table 5) or case series. 15, 17, 19, [26] [27] [28] [29] [30] However, the use of an NSF does not appear to alter QoL in the long term, but can increase nasal crusting and obstruction within the first 6 weeks to 3 months.
Conclusion
The NSF is a robust and reliable reconstructive flap in EES of the skull base. Multiple series have demonstrated its efficacy in reducing CSF leak rates. This systematic review of the literature further supports its safety in endoscopic skull base surgery, showing low rates of reported complications. We hypothesize that some of these complications, such as NSF necrosis and dorsal collapse are likely underreported. The NSF is only one option in the skull base reconstructive ladder, and its use in preventing CSF leaks and covering neurovascular structures must be balanced against its potential morbidities. 
